npj Genomic Medicine (May 2017)

The clinical impact of copy number variants in inherited bone marrow failure syndromes

  • Nicolas Waespe,
  • Santhosh Dhanraj,
  • Manju Wahala,
  • Elena Tsangaris,
  • Tom Enbar,
  • Bozana Zlateska,
  • Hongbing Li,
  • Robert J. Klaassen,
  • Conrad V. Fernandez,
  • Geoff D. E. Cuvelier,
  • John K. Wu,
  • Yves D. Pastore,
  • Mariana Silva,
  • Jeffrey H. Lipton,
  • Joseé Brossard,
  • Bruno Michon,
  • Sharon Abish,
  • MacGregor Steele,
  • Roona Sinha,
  • Mark J. Belletrutti,
  • Vicky R. Breakey,
  • Lawrence Jardine,
  • Lisa Goodyear,
  • Liat Kofler,
  • Michaela Cada,
  • Lillian Sung,
  • Mary Shago,
  • Stephen W. Scherer,
  • Yigal Dror

DOI
https://doi.org/10.1038/s41525-017-0019-2
Journal volume & issue
Vol. 2, no. 1
pp. 1 – 8

Abstract

Read online

Blood disorders: impact of genomic structural variation Copy number variation in patients with inherited bone marrow failure syndromes (IBMFSs) is associated with more severe clinical symptoms. In addition to persistently low levels of red blood cells, white blood cells and/ or platelets, patients with IBMFSs also present varying degrees of physical malformations. Most cases are associated with single base-pair mutations in the DNA sequence, but Canadian researchers led by Yigal Dror at The Hospital for Sick Children in Toronto, have found that whole sections of the genome are deleted or repeated in an important proportion of patients. Those carrying copy number variants (CNV) presented more commonly with developmental delay, short stature and defects in more organ systems, than patients with point mutations. CNV analysis of patients with suspected IBMFSs could aid early disease evaluation and management.